Immuno Cancer Biotherapeutics: Funding, Investors & Team (Oct 2026)
Immuno Cancer Biotherapeutics is developing polyclonal antibody based therapies to target and overcome cancer heterogeneity and resistance.
Immuno Cancer Biotherapeutics has raised $80k across 1 funding round on record, the most recent a Seed of $80k announced in Oct 2026.
That round is below the $7.7M median round size for United States companies tracked on FundedIQ over the last two years.
Immuno Cancer Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Immuno Cancer Biotherapeutics Funding Rounds
Immuno Cancer Biotherapeutics Funding in Context
Immuno Cancer Biotherapeutics' latest round of $80k is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immuno Cancer Biotherapeutics in Biotechnology and Canton
Companies Similar to Immuno Cancer Biotherapeutics
TechNovaTime is a an IT Internet offering AI based automate platform for healthcare teams administrative…
Metabolize provdies wellness and fitness services that helps with global metabolic health and obesity epidemic
Shamrock AI is an enterprise AI platform focused on agentic assurance for SAP and complex enterprise…
ExploreTech AI builds AI-powered tools that combine machine learning and geoscience data to help discover…
Abby Care helps caregivers get Medicaid compensation for caring for children with disabilities or special…
Secure the next endpoint: Enterprise AI (M365 Copilot, ChatGPT, Claude, Gemini). Trusted by UiPath, Wellstar,…
Medcotec designs innovative powder transfer valves to make pharmaceutical manufacturing safer, cleaner, and…
Fission is an institutional liquidity layer connecting asset holders, lending markets, and platforms for…
Guardify is a digital platform that makes evidence management.
Punch is a software platform that provides purchasing and accounts payable tools for construction…
OpsMate AI transforms plant data, documents, and expert knowledge into industrial AI platform that powers…
EMode Photonix develops simulation software for designing nonlinear integrated photonic and quantum photonic…
Immuno Cancer Biotherapeutics Funding FAQs
What does Immuno Cancer Biotherapeutics do?
Immuno Cancer Biotherapeutics is developing polyclonal antibody based therapies to target and overcome cancer heterogeneity and resistance.
How much funding has Immuno Cancer Biotherapeutics raised?
Immuno Cancer Biotherapeutics has raised $80k across 1 round on record. The most recent is a Seed of $80k announced in Oct 2026.
When did Immuno Cancer Biotherapeutics last raise funding?
Immuno Cancer Biotherapeutics' most recent funding round on record is a Seed of $80k, announced in Oct 2026.
Where is Immuno Cancer Biotherapeutics headquartered?
Immuno Cancer Biotherapeutics is based in Canton, United States.
How many employees does Immuno Cancer Biotherapeutics have?
Immuno Cancer Biotherapeutics is in the 1-10 employee band.
When was Immuno Cancer Biotherapeutics founded?
Immuno Cancer Biotherapeutics was founded in 2024.
About FundedIQ's Immuno Cancer Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immuno Cancer Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.